Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), appointed Carole Huntsman Chief Commercial Officer. Huntsman was most recently senior vice president, head of specialty care North America, and U.S. Country Lead at Sanofi, where she directed 2,600 team members across multiple product launches in immunology, neurology, oncology, rare diseases, and rare blood disorders.  From 2012 until joining Madr...